ePrints

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

Lookup NU author(s): Professor Jordi Diaz ManeraORCiD

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Publication metadata

Author(s): Howard JF, Utsugisawa K, Benatar M, Murai H, Barohn RJ, Illa I, Jacob S, Vissing J, Burns TM, Kissel JT, Muppidi S, Nowak RJ, O'Brien F, Wang J-J, Mantegazza R, in collaboration with the REGAIN Study Group

Publication type: Article

Publication status: Published

Journal: The Lancet Neurology

Year: 2017

Volume: 16

Issue: 12

Pages: 976-986

Print publication date: 01/12/2017

Online publication date: 20/10/2017

Acceptance date: 02/04/2016

ISSN (print): 1474-4422

ISSN (electronic): 1474-4465

Publisher: The Lancet Publishing Group

URL: https://doi.org/10.1016/S1474-4422(17)30369-1

DOI: 10.1016/S1474-4422(17)30369-1

Altmetrics

Share